table of content
1 Introduction to Research & Analysis Reports
1.1 Next Generation Diabetes Therapy and Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Diabetes Therapy and Drug Delivery Overall Market Size
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size: 2022 VS 2029
2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
3.2 Top Global Next Generation Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
3.3 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Diabetes Therapy and Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Inhalable Insulin
4.1.3 Oral Insulin
4.1.4 Insulin Patches
4.1.5 CGM Systems
4.1.6 Artificial Pancreas
4.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2022 & 2029
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2029
6.3.2 US Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.3.3 Canada Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2029
6.4.2 Germany Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4.3 France Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4.5 Italy Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4.6 Russia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2029
6.5.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.5.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.5.6 India Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.7.3 Israel Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
6.7.5 UAE Next Generation Diabetes Therapy and Drug Delivery Market Size, 2018-2029
7 Next Generation Diabetes Therapy and Drug Delivery Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Medtronic
7.3.1 Medtronic Company Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Medtronic Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Novo Nordisk
7.5.1 Novo Nordisk Company Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Novo Nordisk Key News & Latest Developments
7.6 MannKind Corporation
7.6.1 MannKind Corporation Company Summary
7.6.2 MannKind Corporation Business Overview
7.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 MannKind Corporation Key News & Latest Developments
7.7 Enteris BioPharma
7.7.1 Enteris BioPharma Company Summary
7.7.2 Enteris BioPharma Business Overview
7.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Enteris BioPharma Key News & Latest Developments
7.8 Dexcom
7.8.1 Dexcom Company Summary
7.8.2 Dexcom Business Overview
7.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Dexcom Key News & Latest Developments
7.9 Senseonics
7.9.1 Senseonics Company Summary
7.9.2 Senseonics Business Overview
7.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Senseonics Key News & Latest Developments
7.10 Medtech
7.10.1 Medtech Company Summary
7.10.2 Medtech Business Overview
7.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Medtech Key News & Latest Developments
7.11 Synertech
7.11.1 Synertech Company Summary
7.11.2 Synertech Business Overview
7.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Synertech Key News & Latest Developments
7.12 Zosano Pharma
7.12.1 Zosano Pharma Company Summary
7.12.2 Zosano Pharma Business Overview
7.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.12.5 Zosano Pharma Key News & Latest Developments
7.13 Relmada Therapeutics
7.13.1 Relmada Therapeutics Company Summary
7.13.2 Relmada Therapeutics Business Overview
7.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.13.5 Relmada Therapeutics Key News & Latest Developments
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Company Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.14.5 Eli Lilly and Company Key News & Latest Developments
7.15 Transdermal Specialties
7.15.1 Transdermal Specialties Company Summary
7.15.2 Transdermal Specialties Business Overview
7.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.15.5 Transdermal Specialties Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
